Anabel Costa-Ferreira

Anabel Costa-Ferreira

Reporter

Anabel is a Reporter, working across the six Citeline publications. She is a recent graduate from the University of Exeter and holds a BA English degree. Since graduating, Anabel has also completed an editorial internship with the In Vivo team. Before joining Norstella she spent the past year as Editor-in-Chief of her university’s student paper, Exeposé, managing an editorial team to produce a 32-page paper on a fortnightly basis.

Latest from Anabel Costa-Ferreira

European Pharmacopoeia Adopts New Standards To Accelerate mRNA Vaccine Development

New general texts to be published in the European Pharmacopoeia in July 2025 are intended to support the rapidly developing mRNA vaccine field, which become an increasingly important technology in recent years.

Global Pharma Guidance Tracker – December 2024

Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.

Global Medtech Guidance Tracker: December 2024

Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. 65 documents have been posted on the tracker since its last update.

Quotable: Top Experts On Policy Hot Topics

The Pink Sheet highlights recent comments and insights from pharma officials and executives on key issues we are covering.

EU Regulators Gear Up for Alzheimer’s Treatment Challenges

Many of the recommendations listed in a new report, which aims to prepare the European medicines regulatory network (EMRN) for Alzheimer’s disease development challenges, will form part of EMRN’s future plans.

Data: The Clinical Trials Space Rebounds

The complex landscape of clinical trials, fraught with pressures and risks, and exacerbated by the adoption of new technologies, regulatory burdens, and drug pricing negotiations, is rebounding with aplomb.